Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer
Open Access
- 30 October 2024
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 16 (12) , 3184-3217
Abstract
Cancer cell plasticity contributes significantly to the failure of chemo- and targeted therapies in triple-negative breast cancer (TNBC). Molecular mechanisms of therapy-induced tumor cell plasticity and associated resistance are largely unknown. Using a genome-wide CRISPR-Cas9 screen, we investigated escape mechanisms of NOTCH-driven TNBC treated with a gamma-secretase inhibitor (GSI) and identified SOX2 as a target of resistance to Notch inhibition. We describe a novel reciprocal inhibitory feedback mechanism between Notch signaling and SOX2. Specifically, Notch signaling inhibits SOX2 expression through its target genes of the HEY family, and SOX2 inhibits Notch signaling through direct interaction with RBPJ. This mechanism shapes divergent cell states with NOTCH positive TNBC being more epithelial-like, while SOX2 expression correlates with epithelial-mesenchymal transition, induces cancer stem cell features and GSI resistance. To counteract monotherapy-induced tumor relapse, we assessed GSI-paclitaxel and dasatinib-paclitaxel combination treatments in NOTCH inhibitor-sensitive and -resistant TNBC xenotransplants, respectively. These distinct preventive combinations and second-line treatment option dependent on NOTCH1 and SOX2 expression in TNBC are able to induce tumor growth control and reduce metastatic burden.Keywords
Funding Information
- FondAction contre le Cancer
This publication has 62 references indexed in Scilit:
- Deciphering breast cancer: from biology to the clinicCell, 2023
- SOX2 in development and cancer biologySeminars in Cancer Biology, 2020
- Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D CliquesMolecular Cell, 2019
- Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerClinical Breast Cancer, 2018
- A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone ResponseCancer Cell, 2016
- Notch3‐specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel‐resistant ovarian cancer cellsMolecular Carcinogenesis, 2015
- Hey bHLH Transcription Factors2014
- Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responsesEMBO Molecular Medicine, 2013
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cellsCancer Letters, 2013
- Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapyLaboratory Investigation, 2011